Polaris Pharmaceuticals Adopts Medidata Payments

Article

Medidata has announced that Polaris Pharmaceuticals has selected Medidata Payments to integrate its clinical trial site reimbursement process.

Medidata has announced that Polaris Pharmaceuticals has selected Medidata Payments to integrate its clinical trial site reimbursement process. Medidata Payments has the ability to pay clinical research sites worldwide and for use across hundreds of studies.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.